Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin C studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin CVitamin C (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 73% Improvement Relative Risk Symp. case 33% Vitamin C  Turobkulovich et al.  Prophylaxis Is prophylaxis with vitamin C beneficial for COVID-19? Prospective study of 45 patients in Uzbekistan Fewer symptomatic cases with vitamin C (p=0.027) c19early.org Turobkulovich et al., Emergent: J. Edu.., Jan 2023 Favors vitamin C Favors control

Applications of quercetin for the prevention of COVID-19 in healthcare workers

Turobkulovich et al., Emergent: Journal of Educational Discoveries and Lifelong Learning
Jan 2023  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin C for COVID-19
6th treatment shown to reduce risk in September 2020
 
*, now known with p = 0.000000087 from 70 studies, recognized in 11 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
Prospective study of healthcare workers in Uzbekistan showing lower cases with vitamin C prophylaxis. Very minimal details are provided, there is no baseline information, and control mortality is very high.
This study is excluded in meta analysis: minimal information, no baseline details, very high control mortality without explanation.
Study covers vitamin C and quercetin.
risk of death, 73.3% lower, RR 0.27, p = 0.11, treatment 2 of 25 (8.0%), control 6 of 20 (30.0%), NNT 4.5.
risk of symptomatic case, 32.6% lower, RR 0.67, p = 0.03, treatment 16 of 25 (64.0%), control 19 of 20 (95.0%), NNT 3.2.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Turobkulovich et al., 25 Jan 2023, prospective, Uzbekistan, peer-reviewed, 2 authors.
This PaperVitamin CAll
APPLICATIONS OF QUERCETIN FOR THE PREVENTION OF COVID-19 IN HEALTHCARE WORKERS Babanazarov Umid Turobkulovich, Sharopov Umarxo`ja Ravshanovich Bukhara State Medical Institute
The topic of coronavirus infection is becoming more and more relevant, especially during the pandemic of this infection. Also, it is important to study the effects of known drugs on the infectivity and course of SARS-CoV-2 infection. This article reveals significant positive results when using the drug quertin and its combination with ascorbic acid on the morbidity rate of medical workers working with COVID-19 patients.
References
Babanazarov Umid Turobkulovich, Kayimov, Tuymurodovich, Coronavirus Infection -A Trigger Factor in Liver Damage, Eurasian Research Bulletin
Oblokulov, Musaeva, Elmurodova, Clinical and epidemiological characteristics of a new coronavirus infection (COVID-19) // New day in medicine
Salieva, Azizov, Dadakhonova, Musayeva, On improving health care// Achievements of science and education
Samadov, Musayeva, The trend of the development of the epidemic process of hepatitis C in Uzbekistan // Materials of the IV International Scientific and Practical Conference "Liki -lyudini. Suchasni problems pharmacotherapy i priznachennya likarskikh zasobiv
Sh, Saitov Sh, Nabieva, Nutritional requirements and the use of biologically active additives in COVID-19 // New Day in medicine
Бабаназаров, Уроков, Бахронов, Заболевания, None, ПЕЧЕНИ ВО ВРЕМЯ ПАНДЕМИИ COVID-19
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit